Vice Health and Wellness Inc. (CNSX:VICE) signed non-binding Letter of Intent to acquire Naltrexone Therapeutics Inc. on July 24, 2023. The total consideration for the transaction is 10 million common shares of Vice at a deemed value of CAD 0.05 per share. The Company anticipates closing the transaction within 30 days, subject to final due diligence.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -50.00% |
|
-.--% | -50.00% |
Jan. 16 | Vice Health and Wellness Inc. Appoints Mr. Cody Corrubia as Corporate Secretary | CI |
Jan. 16 | Vice Health and Wellness Inc. Appoints Mr. Cody Corrubia as CFO | CI |
1st Jan change | Capi. | |
---|---|---|
-50.00% | 160K | |
-.--% | 843M | |
0.00% | 669M | |
+12.92% | 218M | |
0.00% | 143M | |
+191.30% | 81.14M | |
-7.96% | 54.15M |
- Stock Market
- Equities
- VICE Stock
- News Vice Health and Wellness Inc.
- Vice Health and Wellness Inc. signed non-binding Letter of Intent to acquire Naltrexone Therapeutics Inc.